Roots Analysis

NOVEMBER 30, 2021

Bioassay – A Prerequisite for the Cell and Gene Therapy Development. Over the past few years, investigational new drug (IND) filings for cell and gene therapy product have significantly increased. Companies Offering Bioassay Services for Cell and Gene Therapies.

Bioassay 52

Bioassay Gene Therapy Gene Development 52

pharmaphorum

SEPTEMBER 26, 2022

The past twelve months have culminated in an unprecedented level of excitement, investment, and clinical progress within the gene therapy field. This year’s agenda includes a novel track designed for quality control and process development groups working in gene therapy. Download the full event guide to find out more.

Gene Therapy 52

Gene Therapy Gene Development Bioassay 52

Roots Analysis

JANUARY 16, 2023

In the health industry, digitization has evolved over time with numerous advances to ensure that everyone has equitable access to health products and medical specialists. Gene Editing beyond CRISPR Market, 2022-2035. Cell and Gene Therapy Bioassay Services Market, 2021-2030. Our Social Media Platform.

Bioassay 52

Bioassay Gene Editing Marketing Gene Therapy 52

Drug Discovery World

NOVEMBER 9, 2023

Thomas Valerius, MD, Professor, Stem Cell Transplantation & Immunotherapy, Christian Albrechts University of Kiel, on: ‘Neutrophil-activating therapy for the treatment of cancer’. Lei Shi, PhD, Senior Vice President, R&D, Biointron Biological, on: ‘Accelerating early discovery through htp and high-speed antibody production’.

Engineer 52

Engineer Antibody Protein In-Vivo 52